Skip to main content
Endocrine Reviews logoLink to Endocrine Reviews
. 2021 Dec 14;43(2):440. doi: 10.1210/endrev/bnab044

Erratum to: Personalized Management of Pheochromocytoma and Paraganglioma

PMCID: PMC8905331  PMID: 34904637

In the above-named article by Nölting S, Bechmann N, Taieb D, Beuschlein F, Fassnacht M, Kroiss M, Eisenhofer G, Grossman A, and Pacak K (Endocrine Reviews 2021; doi: 10.1210/endrev/bnab019), the following error occurred during typesetting:

Index numbers of some citations in the text of the article after the subheading “Chemotherapy: cyclophosphamide/vincristine/dacarbazine scheme and temozolomide” on page 21 were incorrect.

These have been corrected in the article online.

The publisher acknowledges the error.

doi: 10.1210/endrev/bnab019


Articles from Endocrine Reviews are provided here courtesy of The Endocrine Society

RESOURCES